Category: Prescription Drugs
Global Prescription Drugs
-
Ophthalmology Drugs Global Market Opportunities And Strategies To 2031
... need to assess the global ophthalmology drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 50 ... Read More
-
Global Pet Obesity Management Market Size study & Forecast, by Product (Drugs, Food Supplements), By Animal Type (Dogs, Cats), By End Use (Pet Specialty Stores, E-commerce), and Regional Analysis, 2022-2029
... is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2029. Pet Obesity Management refers to the ... Read More
-
Global Drug-eluting Balloon Catheters Market Size study & Forecast, by Drug (Paclitaxel, Sirolimus, Others) by Indication (Coronary Intervention, Peripheral Intervention), by End-user (Hospitals & ASCs, Specialty Clinics and Catheterization Laboratories) and Regional Analysis, 2022-2029
... Drug-eluting Balloon Catheters Market is valued at approximately USD 529.4 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.9% over the forecast period 2022-2029. Drug-eluting balloon catheters ... Read More
-
Global Treatment-resistant Depression Treatment Market Size study & Forecast, by Drug Type (NMDA, Antidepressants, Antipsychotics, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and Regional Analysis, 2022-2029
... Treatment Market is valued at approximately USD 1.52 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2022-2029. Treatment-Resistant Depression (TRD) is a ... Read More
-
Blood-Brain Barrier Technologies Market Analysis And Forecast To 2032: By Application (Alzheimer Disease, Epilepsy, Parkinson Disease, Multiple Sclerosis, Hunter Syndrome, Brain Cancer), By Technology (Bispecific Antibody RMT Approach, Trojan Horse Approach, Increasing Permeability, Passive Diffusion, Others), By End-Use (Hospitals, Surgical centers, Research Institutes, Others), And Region
... period. Blood-brain barrier (BBB) is one of the main components of the neurovascular unit and serves as the blood-brain interface to mediate communication between the central nervous system and the periphery. It prevents pathogens and ... Read More
-
Ophthalmology Drugs Global Market Briefing 2023
... market was $7.2 and in terms of global GDP, the market was 0.05%. Ophthalmology drugs was the ninth largest segment within the market accounting for 3.5% preceded and followed by gastrointestinal drugs and at 4.7% ... Read More
-
Pharmaceuticals Global Market Briefing 2023
... drugs was the largest segment within the pharmaceuticals market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs at 11.2%. Pharmaceuticals Global Market Briefing 2023 provides strategists, marketers and senior ... Read More
-
Oncology Drugs Global Market Briefing 2023
... market was $28.5 and in terms of global GDP, the market was 0.20%. Oncology drugs was the second largest segment within the market accounting for 13.9% preceded and followed by anti-infective drugs at 15.5% and ... Read More
-
Cardiovascular Drugs Global Market Briefing 2023
... market was $19.8 and in terms of global GDP, the market was 0.14%. Cardiovascular drugs was the fifth largest segment within the market accounting for 9.6% preceded and followed by respiratory diseases drugs at 9.7% ... Read More
-
Metabolic Disorders Drugs Global Market Briefing 2023
... consumption, the market was $11.7 and in terms of global GDP, the market was 0.08%. Metabolic disorders drugs was the seventh largest segment within the market accounting for 5.7% preceded and followed by musculoskeletal disorders ... Read More
-
Anti-Infective Drugs Global Market Briefing 2023
... was $31.8 and in terms of global GDP, the market was 0.23%. Anti-infective drugs was the largest segment within the market accounting for 15.5% followed by oncology drugs at 13.9% and central nervous system drugs ... Read More
-
Genito-Urinary Drugs Global Market Briefing 2023
... market was $5.5 and in terms of global GDP, the market was 0.04%. Genito-urinary drugs was the eleventh largest segment within the market accounting for 2.6% preceded and followed by dermatology drugs at 3.4% and ... Read More
-
Animal Medicine Global Market Briefing 2023
... consumption, the market was $6.0 and in terms of global GDP, the market was 0.04%. Animal Medicine was the second largest segment within the veterinary healthcare market accounting for 26.0% preceded and followed by veterinary ... Read More
-
Respiratory Diseases Drugs Global Market Briefing 2023
... consumption, the market was $19.8 and in terms of global GDP, the market was 0.14%. Respiratory diseases drugs was the fourth largest segment within the market accounting for 9.7% preceded and followed by central nervous ... Read More
-
Hematology Drugs Global Market Briefing 2023
... market was $4.6 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.6% and dermatology drugs ... Read More
-
Central Nervous System Drugs Global Market Briefing 2023
... per capita consumption, the market was $23.1 and in terms of global GDP, the market was 0.16%. Central nervous system drugs was the third largest segment within the market accounting for 11.2% preceded and followed ... Read More
-
Dermatology Drugs Global Market Briefing 2023
... market was $7.1 and in terms of global GDP, the market was 0.05%. Dermatology drugs was the tenth largest segment within the market accounting for 3.4% preceded and followed by ophthalmology drugs at 3.5% and ... Read More
-
Gastrointestinal Drugs Global Market Briefing 2023
... market was $9.7 and in terms of global GDP, the market was 0.07%. Gastrointestinal drugs was the eighth largest segment within the market accounting for 4.7% preceded and followed by metabolic disorders drugs at 5.7% ... Read More
-
Musculoskeletal Disorders Drugs Global Market Briefing 2023
... consumption, the market was $13.4 and in terms of global GDP, the market was 0.09%. Musculoskeletal disorders drugs was the sixth largest segment within the market accounting for 6.5% preceded and followed by cardiovascular drugs ... Read More
-
Anti-Obesity Drugs Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... was observed that obesity had increased exponentially. As per an article published by the European Journal of Nutrition in December 2020, the rate of obesity has increased in the world. The major reason is a ... Read More
-
Behavioral Rehabilitation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 323.6 Billion by 2028, exhibiting a growth rate (CAGR) of 4.4% during 2023-2028. Behavioral rehabilitation refers to a psychotherapeutic technique used for the treatment of specific learned behaviors that are detrimental to the wellbeing of ... Read More
-
Global Menopause Supplement Market Growth 2023-2029
... region and market sector of projected Menopause Supplement sales for 2023 through 2029. With Menopause Supplement sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of ... Read More
-
Global Air Freight Healthcare Cold Chain Logistics Market Growth (Status and Outlook) 2023-2029
... world Air Freight Healthcare Cold Chain Logistics sales in 2022, providing a comprehensive analysis by region and market sector of projected Air Freight Healthcare Cold Chain Logistics sales for 2023 through 2029. With Air Freight ... Read More
-
Medication Management Market by Software (Computerized Physician Order Entry System, Clinical Decision Support System, Administration Software, Inventory Management System, Automated Dispensing Systems, Assurance System), Services (Medication Analytics Se
... Surveillance Services), Mode of Delivery (Web-based, Cloud-based, On-premises), End User (Pharmacies, Hospitals and Others) and Region 2023-2028 The global medication management market size reached US$ 2.7 Billion in 2022. Looking forward, IMARC Group expects the ... Read More
-
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Other
... epilepsy drugs market size reached US$ 2.16 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.52 Billion by 2028, exhibiting a growth rate (CAGR) of 8.2% during 2023-2028. The rising ... Read More
Research Assistance
